Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...
In a pooled analysis of clinical trial data on diabetic patients at high cardiovascular risk or with chronic kidney disease, canagliflozin demonstrated consistent benefits across the spectrum of age ...
As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...